Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease
- 10 June 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 128 (12) , 1988-2002
Abstract
Venous disease is a term that broadly covers both venous thromboembolic disease and chronic venous disease. The basic pathophysiology of venous thromboembolism and chronic venous disease differ as venous thromboembolism results from an imbalance of hemostasis and thrombosis while chronic venous disease occurs in the setting of tissue damage because of prolonged venous hypertension. Both diseases are common and account for significant mortality and morbidity, respectively, and collectively make up a large health care burden. Despite both diseases having well-characterized environmental components, it has been known for decades that family history is an important risk factor, implicating a genetic element to a patient’s risk. Our understanding of the pathogenesis of these diseases has greatly benefited from an expansion of population genetic studies from pioneering familial studies to large genome-wide association studies; we now have multiple risk loci for each venous disease. In this review, we will highlight the current state of knowledge on the epidemiology and genetics of venous thromboembolism and chronic venous disease and directions for future research.Keywords
This publication has 118 references indexed in Scilit:
- A Review of Familial, Genetic, and Congenital Aspects of Primary Varicose Vein DiseaseCirculation: Cardiovascular Genetics, 2012
- Genetics of Venous Thrombosis: Insights from a New Genome Wide Association StudyPLOS ONE, 2011
- Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosisBlood, 2011
- Heritability of chronic venous diseaseHuman Genetics, 2010
- Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand FactorCirculation, 2010
- Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approachBlood, 2009
- Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veinsJournal of Vascular Surgery, 2008
- Chronic Venous DiseaseNew England Journal of Medicine, 2006
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Atrial Natriuretic Factor Release During Volume Expansion in the Spontaneously Hypertensive Rat - Effect of Long-Term Hydralazine TreatmentClinical and Experimental Hypertension. Part A: Theory and Practice, 1991